These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 18390465)
1. Bioterrorism: class A agents and their potential presentations in immunocompromised patients. Richard JL; Grimes DE Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465 [TBL] [Abstract][Full Text] [Related]
2. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism. Altman GB Nurs Manage; 2002 Jan; 33(1):43, 45-7. PubMed ID: 11984331 [TBL] [Abstract][Full Text] [Related]
3. Molecular diagnostic techniques for use in response to bioterrorism. Firmani MA; Broussard LA Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181 [TBL] [Abstract][Full Text] [Related]
4. [Bioterrorism]. Sata T Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383 [TBL] [Abstract][Full Text] [Related]
5. Oncology nursing implications related to smallpox bioterrorism preparations. Mack K Clin J Oncol Nurs; 2004 Feb; 8(1):51-5. PubMed ID: 14983764 [TBL] [Abstract][Full Text] [Related]
6. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Cosgrove SE; Perl TM; Song X; Sisson SD Arch Intern Med; 2005 Sep; 165(17):2002-6. PubMed ID: 16186470 [TBL] [Abstract][Full Text] [Related]
7. Recognition and management of bioterrorism infections. O'Brien KK; Higdon ML; Halverson JJ Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654 [TBL] [Abstract][Full Text] [Related]
8. Drugs and vaccines against biological weapons. Conn Med; 2001 Dec; 65(12):719-20. PubMed ID: 11797482 [No Abstract] [Full Text] [Related]
10. Clinical management of potential bioterrorism-related conditions. Adalja AA; Toner E; Inglesby TV N Engl J Med; 2015 Mar; 372(10):954-62. PubMed ID: 25738671 [TBL] [Abstract][Full Text] [Related]
11. [Germs and toxins in bioterrorism]. Inoue N Nihon Rinsho; 2003 Feb; 61 Suppl 2():81-91. PubMed ID: 12722194 [No Abstract] [Full Text] [Related]
12. Clinical and pathologic differential diagnosis of selected potential bioterrorism agents of interest to pediatric health care providers. Stocker JT Clin Lab Med; 2006 Jun; 26(2):329-44, viii. PubMed ID: 16815456 [TBL] [Abstract][Full Text] [Related]
13. Biological agents: weapons of warfare and bioterrorism. Broussard LA Mol Diagn; 2001 Dec; 6(4):323-33. PubMed ID: 11774197 [TBL] [Abstract][Full Text] [Related]
14. Being prepared: bioterrorism and mass prophylaxis: part II. Weant KA; Bailey AM; Fleishaker EL; Justice SB Adv Emerg Nurs J; 2014; 36(4):307-17; quiz 318-9. PubMed ID: 25356890 [TBL] [Abstract][Full Text] [Related]
15. Bioterrorism for the respiratory physician. Waterer GW; Robertson H Respirology; 2009 Jan; 14(1):5-11. PubMed ID: 19144044 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations of category A bioweapons. Aquino LL; Wu JJ J Am Acad Dermatol; 2011 Dec; 65(6):1213.e1-1213.e15. PubMed ID: 21777993 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary disease from biological agents: anthrax, plague, Q fever, and tularemia. Daya M; Nakamura Y Crit Care Clin; 2005 Oct; 21(4):747-63, vii. PubMed ID: 16168313 [TBL] [Abstract][Full Text] [Related]